We use cookies to provide you with a better experience. If you continue to use this site, we'll assume you're happy with this. Alternatively, click here to find out how to manage these cookies

hide cookie message
AstraZeneca in clinical data reporting deal

AstraZeneca in clinical data reporting deal

Drugs firm to standardise processes

Article comments

Pharmaceutical firm AstraZeneca has signed a large programming and reporting outsourcing deal with Cognizant.

Under the multi-year deal, AstraZeneca said the outsourcer will provide "comprehensive" biostatistics and medical reporting services, aimed at aiding clinical studies.

The deal also covers statistical programming, data analysis, medical writing and document publishing services.

The company already uses Cognizant for business process outsourcing, application maintenance and data management in several divisions.

AstraZeneca intends to cut cycle times and standardise processes as part of the changes, and insisted it would retain the key design and data interpretation elements of clinical trials.

It plans to use the Cognizant 2.0 knowledge sharing and collaboration platform, to assist clinical studies being managed across numerous countries.

Karin Wingstrand, VP at AstraZeneca, said the deal "will help us streamline our clinical development operations".

"This is key to our business transformation aimed at achieving greater efficiency, agility, flexibility, and global competitiveness – all of which are crucial to clinical trials and development of new drugs," she added.

Share:

Comments

Advertisement
Send to a friend

Email this article to a friend or colleague:


PLEASE NOTE: Your name is used only to let the recipient know who sent the story, and in case of transmission error. Both your name and the recipient's name and address will not be used for any other purpose.


ComputerworldUK Knowledge Vault

ComputerworldUK
Share
x
Open
* *